<?xml version="1.0" encoding="UTF-8"?>
<p>ART adherence during the 30 days before the interview was assessed using a three-item scale; responses were aggregated and transformed into a previously validated composite score (range = 0–100), which has high internal reliability and is consistent with electronic drug monitoring measures (
 <xref rid="R4" ref-type="bibr">
  <italic>4</italic>
 </xref>,
 <xref rid="R5" ref-type="bibr">
  <italic>5</italic>
 </xref>). Ancillary services
 <xref ref-type="fn" rid="FN4">
  <sup>¶</sup>
 </xref> were defined as services that enable and support participants’ retention in HIV care (
 <xref rid="R6" ref-type="bibr">
  <italic>6</italic>
 </xref>). Sustained viral suppression was defined as all viral load measurements in the previous 12 months documented as undetectable or &lt;200 viral RNA copies/mL.
 <xref ref-type="fn" rid="FN5">**</xref> Reasons for most recent missed ART dose consisted of predefined options that respondents could select and were limited to the 2018 data cycle because of skip-pattern changes that limited comparability with earlier data cycles.
</p>
